The global Mitral Bioprosthetic Valve market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

The mitral bioprosthesis is a medical device used in heart valve replacement surgery, specifically designed to replace a damaged or dysfunctional native mitral valve. The mitral valve is an important valve located between the left atrium and the left ventricle, and its main function is to ensure unidirectional blood flow in the left chamber of the heart. The bioprosthesis is designed to mimic the structure and function of the natural mitral valve, providing stable blood flow control and reducing blood backflow, thereby restoring the normal function of the heart.

From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Mitral Bioprosthetic Valve leading manufacturers including Labcor, Affluent Medical, Braile Biomedica, Medtronic, Abbott, Sinomed, Edwards Lifesciences, etc., dominate supply; the top five capture approximately % of global revenue, with Labcor leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Mitral Bioprosthetic Valve market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Mitral Bioprosthetic Valve Market Report

Report Metric	Details
Report Name	Mitral Bioprosthetic Valve Market
Segment by Type	Cattle Tissue Pig Tissue
Segment by Application	Hospital Clinic
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Labcor, Affluent Medical, Braile Biomedica, Medtronic, Abbott, Sinomed, Edwards Lifesciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Mitral Bioprosthetic Valve study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Mitral Bioprosthetic Valve Market report?

Ans: The main players in the Mitral Bioprosthetic Valve Market are Labcor, Affluent Medical, Braile Biomedica, Medtronic, Abbott, Sinomed, Edwards Lifesciences

What are the Application segmentation covered in the Mitral Bioprosthetic Valve Market report?

Ans: The Applications covered in the Mitral Bioprosthetic Valve Market report are Hospital, Clinic

What are the Type segmentation covered in the Mitral Bioprosthetic Valve Market report?

Ans: The Types covered in the Mitral Bioprosthetic Valve Market report are Cattle Tissue, Pig Tissue

1 Study Coverage

1.1 Introduction to Mitral Bioprosthetic Valve: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Mitral Bioprosthetic Valve Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Cattle Tissue

1.2.3 Pig Tissue

1.3 Market Segmentation by Application

1.3.1 Global Mitral Bioprosthetic Valve Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Mitral Bioprosthetic Valve Revenue Estimates and Forecasts 2020-2031

2.2 Global Mitral Bioprosthetic Valve Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Mitral Bioprosthetic Valve Sales Estimates and Forecasts 2020-2031

2.4 Global Mitral Bioprosthetic Valve Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Mitral Bioprosthetic Valve Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Mitral Bioprosthetic Valve Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Cattle Tissue Market Size by Manufacturers

3.5.2 Pig Tissue Market Size by Manufacturers

3.6 Global Mitral Bioprosthetic Valve Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Mitral Bioprosthetic Valve Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Mitral Bioprosthetic Valve Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Mitral Bioprosthetic Valve Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Mitral Bioprosthetic Valve Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Mitral Bioprosthetic Valve Sales and Revenue by Type (2020-2031)

6.4 North America Mitral Bioprosthetic Valve Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Mitral Bioprosthetic Valve Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Mitral Bioprosthetic Valve Sales and Revenue by Type (2020-2031)

7.4 Europe Mitral Bioprosthetic Valve Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Mitral Bioprosthetic Valve Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Mitral Bioprosthetic Valve Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Mitral Bioprosthetic Valve Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Mitral Bioprosthetic Valve Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Mitral Bioprosthetic Valve Sales and Revenue by Type (2020-2031)

9.4 Central and South America Mitral Bioprosthetic Valve Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Mitral Bioprosthetic Valve Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Mitral Bioprosthetic Valve Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Mitral Bioprosthetic Valve Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Mitral Bioprosthetic Valve Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Labcor

11.1.1 Labcor Corporation Information

11.1.2 Labcor Business Overview

11.1.3 Labcor Mitral Bioprosthetic Valve Product Models, Descriptions and Specifications

11.1.4 Labcor Mitral Bioprosthetic Valve Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Labcor Mitral Bioprosthetic Valve Sales by Product in 2024

11.1.6 Labcor Mitral Bioprosthetic Valve Sales by Application in 2024

11.1.7 Labcor Mitral Bioprosthetic Valve Sales by Geographic Area in 2024

11.1.8 Labcor Mitral Bioprosthetic Valve SWOT Analysis

11.1.9 Labcor Recent Developments

11.2 Affluent Medical

11.2.1 Affluent Medical Corporation Information

11.2.2 Affluent Medical Business Overview

11.2.3 Affluent Medical Mitral Bioprosthetic Valve Product Models, Descriptions and Specifications

11.2.4 Affluent Medical Mitral Bioprosthetic Valve Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Affluent Medical Mitral Bioprosthetic Valve Sales by Product in 2024

11.2.6 Affluent Medical Mitral Bioprosthetic Valve Sales by Application in 2024

11.2.7 Affluent Medical Mitral Bioprosthetic Valve Sales by Geographic Area in 2024

11.2.8 Affluent Medical Mitral Bioprosthetic Valve SWOT Analysis

11.2.9 Affluent Medical Recent Developments

11.3 Braile Biomedica

11.3.1 Braile Biomedica Corporation Information

11.3.2 Braile Biomedica Business Overview

11.3.3 Braile Biomedica Mitral Bioprosthetic Valve Product Models, Descriptions and Specifications

11.3.4 Braile Biomedica Mitral Bioprosthetic Valve Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Braile Biomedica Mitral Bioprosthetic Valve Sales by Product in 2024

11.3.6 Braile Biomedica Mitral Bioprosthetic Valve Sales by Application in 2024

11.3.7 Braile Biomedica Mitral Bioprosthetic Valve Sales by Geographic Area in 2024

11.3.8 Braile Biomedica Mitral Bioprosthetic Valve SWOT Analysis

11.3.9 Braile Biomedica Recent Developments

11.4 Medtronic

11.4.1 Medtronic Corporation Information

11.4.2 Medtronic Business Overview

11.4.3 Medtronic Mitral Bioprosthetic Valve Product Models, Descriptions and Specifications

11.4.4 Medtronic Mitral Bioprosthetic Valve Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Medtronic Mitral Bioprosthetic Valve Sales by Product in 2024

11.4.6 Medtronic Mitral Bioprosthetic Valve Sales by Application in 2024

11.4.7 Medtronic Mitral Bioprosthetic Valve Sales by Geographic Area in 2024

11.4.8 Medtronic Mitral Bioprosthetic Valve SWOT Analysis

11.4.9 Medtronic Recent Developments

11.5 Abbott

11.5.1 Abbott Corporation Information

11.5.2 Abbott Business Overview

11.5.3 Abbott Mitral Bioprosthetic Valve Product Models, Descriptions and Specifications

11.5.4 Abbott Mitral Bioprosthetic Valve Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Abbott Mitral Bioprosthetic Valve Sales by Product in 2024

11.5.6 Abbott Mitral Bioprosthetic Valve Sales by Application in 2024

11.5.7 Abbott Mitral Bioprosthetic Valve Sales by Geographic Area in 2024

11.5.8 Abbott Mitral Bioprosthetic Valve SWOT Analysis

11.5.9 Abbott Recent Developments

11.6 Sinomed

11.6.1 Sinomed Corporation Information

11.6.2 Sinomed Business Overview

11.6.3 Sinomed Mitral Bioprosthetic Valve Product Models, Descriptions and Specifications

11.6.4 Sinomed Mitral Bioprosthetic Valve Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Sinomed Recent Developments

11.7 Edwards Lifesciences

11.7.1 Edwards Lifesciences Corporation Information

11.7.2 Edwards Lifesciences Business Overview

11.7.3 Edwards Lifesciences Mitral Bioprosthetic Valve Product Models, Descriptions and Specifications

11.7.4 Edwards Lifesciences Mitral Bioprosthetic Valve Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Edwards Lifesciences Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Mitral Bioprosthetic Valve Industry Chain

12.2 Mitral Bioprosthetic Valve Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Mitral Bioprosthetic Valve Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Mitral Bioprosthetic Valve Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Mitral Bioprosthetic Valve Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Mitral Bioprosthetic Valve Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Mitral Bioprosthetic Valve Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Mitral Bioprosthetic Valve Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Mitral Bioprosthetic Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Mitral Bioprosthetic Valve Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Mitral Bioprosthetic Valve Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Mitral Bioprosthetic Valve Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)

Table 7. Global Mitral Bioprosthetic Valve Sales by Region (2020-2025) & (Units)

Table 8. Global Mitral Bioprosthetic Valve Sales by Region (2026-2031) & (Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Mitral Bioprosthetic Valve Sales by Manufacturers (2020-2025) & (Units)

Table 11. Global Mitral Bioprosthetic Valve Sales Share by Manufacturers (2020-2025)

Table 12. Global Mitral Bioprosthetic Valve Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Mitral Bioprosthetic Valve Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Mitral Bioprosthetic Valve by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mitral Bioprosthetic Valve as of 2024)

Table 16. Global Mitral Bioprosthetic Valve Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Mitral Bioprosthetic Valve Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Mitral Bioprosthetic Valve Manufacturing Base and Headquarters

Table 19. Global Mitral Bioprosthetic Valve Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Mitral Bioprosthetic Valve Sales by Type (2020-2025) & (Units)

Table 23. Global Mitral Bioprosthetic Valve Sales by Type (2026-2031) & (Units)

Table 24. Global Mitral Bioprosthetic Valve Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Mitral Bioprosthetic Valve Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Mitral Bioprosthetic Valve ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Mitral Bioprosthetic Valve Sales by Application (2020-2025) & (Units)

Table 29. Global Mitral Bioprosthetic Valve Sales by Application (2026-2031) & (Units)

Table 30. Mitral Bioprosthetic Valve High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Mitral Bioprosthetic Valve Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Mitral Bioprosthetic Valve Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Mitral Bioprosthetic Valve ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Mitral Bioprosthetic Valve Growth Accelerators and Market Barriers

Table 37. North America Mitral Bioprosthetic Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Mitral Bioprosthetic Valve Sales (Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Mitral Bioprosthetic Valve Growth Accelerators and Market Barriers

Table 40. Europe Mitral Bioprosthetic Valve Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Mitral Bioprosthetic Valve Sales (Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Mitral Bioprosthetic Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Mitral Bioprosthetic Valve Sales (Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Mitral Bioprosthetic Valve Growth Accelerators and Market Barriers

Table 45. Southeast Asia Mitral Bioprosthetic Valve Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Mitral Bioprosthetic Valve Investment Opportunities and Key Challenges

Table 47. Central and South America Mitral Bioprosthetic Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Mitral Bioprosthetic Valve Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Mitral Bioprosthetic Valve Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Labcor Corporation Information

Table 51. Labcor Description and Major Businesses

Table 52. Labcor Product Models, Descriptions and Specifications

Table 53. Labcor Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Labcor Sales Value Proportion by Product in 2024

Table 55. Labcor Sales Value Proportion by Application in 2024

Table 56. Labcor Sales Value Proportion by Geographic Area in 2024

Table 57. Labcor Mitral Bioprosthetic Valve SWOT Analysis

Table 58. Labcor Recent Developments

Table 59. Affluent Medical Corporation Information

Table 60. Affluent Medical Description and Major Businesses

Table 61. Affluent Medical Product Models, Descriptions and Specifications

Table 62. Affluent Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Affluent Medical Sales Value Proportion by Product in 2024

Table 64. Affluent Medical Sales Value Proportion by Application in 2024

Table 65. Affluent Medical Sales Value Proportion by Geographic Area in 2024

Table 66. Affluent Medical Mitral Bioprosthetic Valve SWOT Analysis

Table 67. Affluent Medical Recent Developments

Table 68. Braile Biomedica Corporation Information

Table 69. Braile Biomedica Description and Major Businesses

Table 70. Braile Biomedica Product Models, Descriptions and Specifications

Table 71. Braile Biomedica Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Braile Biomedica Sales Value Proportion by Product in 2024

Table 73. Braile Biomedica Sales Value Proportion by Application in 2024

Table 74. Braile Biomedica Sales Value Proportion by Geographic Area in 2024

Table 75. Braile Biomedica Mitral Bioprosthetic Valve SWOT Analysis

Table 76. Braile Biomedica Recent Developments

Table 77. Medtronic Corporation Information

Table 78. Medtronic Description and Major Businesses

Table 79. Medtronic Product Models, Descriptions and Specifications

Table 80. Medtronic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Medtronic Sales Value Proportion by Product in 2024

Table 82. Medtronic Sales Value Proportion by Application in 2024

Table 83. Medtronic Sales Value Proportion by Geographic Area in 2024

Table 84. Medtronic Mitral Bioprosthetic Valve SWOT Analysis

Table 85. Medtronic Recent Developments

Table 86. Abbott Corporation Information

Table 87. Abbott Description and Major Businesses

Table 88. Abbott Product Models, Descriptions and Specifications

Table 89. Abbott Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Abbott Sales Value Proportion by Product in 2024

Table 91. Abbott Sales Value Proportion by Application in 2024

Table 92. Abbott Sales Value Proportion by Geographic Area in 2024

Table 93. Abbott Mitral Bioprosthetic Valve SWOT Analysis

Table 94. Abbott Recent Developments

Table 95. Sinomed Corporation Information

Table 96. Sinomed Description and Major Businesses

Table 97. Sinomed Product Models, Descriptions and Specifications

Table 98. Sinomed Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Sinomed Recent Developments

Table 100. Edwards Lifesciences Corporation Information

Table 101. Edwards Lifesciences Description and Major Businesses

Table 102. Edwards Lifesciences Product Models, Descriptions and Specifications

Table 103. Edwards Lifesciences Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Edwards Lifesciences Recent Developments

Table 105. Key Raw Materials Distribution

Table 106. Raw Materials Key Suppliers

Table 107. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 108. Milestones in Production Technology Evolution

Table 109. Distributors List

Table 110. Market Trends and Market Evolution

Table 111. Market Drivers and Opportunities

Table 112. Market Challenges, Risks, and Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Mitral Bioprosthetic Valve Product Picture

Figure 2. Global Mitral Bioprosthetic Valve Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Cattle Tissue Product Picture

Figure 4. Pig Tissue Product Picture

Figure 5. Global Mitral Bioprosthetic Valve Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Hospital

Figure 7. Clinic

Figure 8. Mitral Bioprosthetic Valve Report Years Considered

Figure 9. Global Mitral Bioprosthetic Valve Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 10. Global Mitral Bioprosthetic Valve Revenue (2020-2031) & (US$ Million)

Figure 11. Global Mitral Bioprosthetic Valve Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 12. Global Mitral Bioprosthetic Valve Revenue Market Share by Region (2020-2031)

Figure 13. Global Mitral Bioprosthetic Valve Sales (2020-2031) & (Units)

Figure 14. Global Mitral Bioprosthetic Valve Sales (CAGR) by Region (2020-2031) (Units)

Figure 15. Global Mitral Bioprosthetic Valve Sales Market Share by Region (2020-2031)

Figure 16. Top 5 and Top 10 Manufacturers Mitral Bioprosthetic Valve Sales Volume Market Share in 2024

Figure 17. Global Mitral Bioprosthetic Valve Revenue Market Share Ranking (2024)

Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 19. Cattle Tissue Revenue Market Share by Manufacturer in 2024

Figure 20. Pig Tissue Revenue Market Share by Manufacturer in 2024

Figure 21. Global Mitral Bioprosthetic Valve Sales Market Share by Type (2020-2031)

Figure 22. Global Mitral Bioprosthetic Valve Revenue Market Share by Type (2020-2031)

Figure 23. Global Mitral Bioprosthetic Valve Sales Market Share by Application (2020-2031)

Figure 24. Global Mitral Bioprosthetic Valve Revenue Market Share by Application (2020-2031)

Figure 25. North America Mitral Bioprosthetic Valve Sales YoY (2020-2031) & (Units)

Figure 26. North America Mitral Bioprosthetic Valve Revenue YoY (2020-2031) & (US$ Million)

Figure 27. North America Top 5 Manufacturers Mitral Bioprosthetic Valve Sales Revenue (US$ Million) in 2024

Figure 28. North America Mitral Bioprosthetic Valve Sales Volume (Units) by Type (2020- 2031)

Figure 29. North America Mitral Bioprosthetic Valve Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 30. North America Mitral Bioprosthetic Valve Sales Volume (Units) by Application (2020-2031)

Figure 31. North America Mitral Bioprosthetic Valve Sales Revenue (US$ Million) by Application (2020-2031)

Figure 32. US Mitral Bioprosthetic Valve Revenue (2020-2031) & (US$ Million)

Figure 33. Canada Mitral Bioprosthetic Valve Revenue (2020-2031) & (US$ Million)

Figure 34. Mexico Mitral Bioprosthetic Valve Revenue (2020-2031) & (US$ Million)

Figure 35. Europe Mitral Bioprosthetic Valve Sales YoY (2020-2031) & (Units)

Figure 36. Europe Mitral Bioprosthetic Valve Revenue YoY (2020-2031) & (US$ Million)

Figure 37. Europe Top 5 Manufacturers Mitral Bioprosthetic Valve Sales Revenue (US$ Million) in 2024

Figure 38. Europe Mitral Bioprosthetic Valve Sales Volume (Units) by Type (2020-2031)

Figure 39. Europe Mitral Bioprosthetic Valve Sales Revenue (US$ Million) by Type (2020-2031)

Figure 40. Europe Mitral Bioprosthetic Valve Sales Volume (Units) by Application (2020-2031)

Figure 41. Europe Mitral Bioprosthetic Valve Sales Revenue (US$ Million) by Application (2020-2031)

Figure 42. Germany Mitral Bioprosthetic Valve Revenue (2020-2031) & (US$ Million)

Figure 43. France Mitral Bioprosthetic Valve Revenue (2020-2031) & (US$ Million)

Figure 44. U.K. Mitral Bioprosthetic Valve Revenue (2020-2031) & (US$ Million)

Figure 45. Italy Mitral Bioprosthetic Valve Revenue (2020-2031) & (US$ Million)

Figure 46. Russia Mitral Bioprosthetic Valve Revenue (2020-2031) & (US$ Million)

Figure 47. Asia-Pacific Mitral Bioprosthetic Valve Sales YoY (2020-2031) & (Units)

Figure 48. Asia-Pacific Mitral Bioprosthetic Valve Revenue YoY (2020-2031) & (US$ Million)

Figure 49. Asia-Pacific Top 8 Manufacturers Mitral Bioprosthetic Valve Sales Revenue (US$ Million) in 2024

Figure 50. Asia-Pacific Mitral Bioprosthetic Valve Sales Volume (Units) by Type (2020- 2031)

Figure 51. Asia-Pacific Mitral Bioprosthetic Valve Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 52. Asia-Pacific Mitral Bioprosthetic Valve Sales Volume (Units) by Application (2020-2031)

Figure 53. Asia-Pacific Mitral Bioprosthetic Valve Sales Revenue (US$ Million) by Application (2020-2031)

Figure 54. Indonesia Mitral Bioprosthetic Valve Revenue (2020-2031) & (US$ Million)

Figure 55. Japan Mitral Bioprosthetic Valve Revenue (2020-2031) & (US$ Million)

Figure 56. South Korea Mitral Bioprosthetic Valve Revenue (2020-2031) & (US$ Million)

Figure 57. China Taiwan Mitral Bioprosthetic Valve Revenue (2020-2031) & (US$ Million)

Figure 58. India Mitral Bioprosthetic Valve Revenue (2020-2031) & (US$ Million)

Figure 59. Central and South America Mitral Bioprosthetic Valve Sales YoY (2020-2031) & (Units)

Figure 60. Central and South America Mitral Bioprosthetic Valve Revenue YoY (2020-2031) & (US$ Million)

Figure 61. Central and South America Top 5 Manufacturers Mitral Bioprosthetic Valve Sales Revenue (US$ Million) in 2024

Figure 62. Central and South America Mitral Bioprosthetic Valve Sales Volume (Units) by Type (2021-2031)

Figure 63. Central and South America Mitral Bioprosthetic Valve Sales Revenue (US$ Million) by Type (2020-2031)

Figure 64. Central and South America Mitral Bioprosthetic Valve Sales Volume (Units) by Application (2020-2031)

Figure 65. Central and South America Mitral Bioprosthetic Valve Sales Revenue (US$ Million) by Application (2020-2031)

Figure 66. Brazil Mitral Bioprosthetic Valve Revenue (2020-2025) & (US$ Million)

Figure 67. Argentina Mitral Bioprosthetic Valve Revenue (2020-2025) & (US$ Million)

Figure 68. Middle East, and Africa Mitral Bioprosthetic Valve Sales YoY (2020-2031) & (Units)

Figure 69. Middle East and Africa Mitral Bioprosthetic Valve Revenue YoY (2020-2031) & (US$ Million)

Figure 70. Middle East and Africa Top 5 Manufacturers Mitral Bioprosthetic Valve Sales Revenue (US$ Million) in 2024

Figure 71. Middle East and Africa Mitral Bioprosthetic Valve Sales Volume (Units) by Type (2021-2031)

Figure 72. South America Mitral Bioprosthetic Valve Sales Revenue (US$ Million) by Type (2020-2031)

Figure 73. Middle East and Africa Mitral Bioprosthetic Valve Sales Volume (Units) by Application (2020-2031)

Figure 74. Middle East and Africa Mitral Bioprosthetic Valve Sales Revenue (US$ Million) by Application (2020-2031)

Figure 75. GCC Countries Mitral Bioprosthetic Valve Revenue (2020-2025) & (US$ Million)

Figure 76. Turkey Mitral Bioprosthetic Valve Revenue (2020-2025) & (US$ Million)

Figure 77. Egypt Mitral Bioprosthetic Valve Revenue (2020-2025) & (US$ Million)

Figure 78. South Africa Mitral Bioprosthetic Valve Revenue (2020-2025) & (US$ Million)

Figure 79. Mitral Bioprosthetic Valve Industry Chain Mapping

Figure 80. Regional Mitral Bioprosthetic Valve Manufacturing Base Distribution (%)

Figure 81. Global Mitral Bioprosthetic Valve Production Market Share by Region (2020-2031)

Figure 82. Mitral Bioprosthetic Valve Production Process

Figure 83. Regional Mitral Bioprosthetic Valve Production Cost Structure

Figure 84. Channels of Distribution (Direct Vs Distribution)

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32P14840

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Point-of-care Troponin Testing Instrument Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22I19939

Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Troponin Analyzer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38W19812

Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Anticoagulant Medications Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-39V16824

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions